U.S. Equity Research
Merging ideas, access and intelligence with our best-in-class execution platform
Cantor Fitzgerald’s Equity Research team provides research-driven trading insight for a broad array of investing strategies. Our U.S. Equity Research team is comprised of 13 analysts covering over 127 stocks across four industry verticals that include healthcare, real estate, retail, and technology. Our approach enables us to provide in-depth and objective industry knowledge to drive ideas and help clients make important investment decisions.
Our analysts actively seek out companies to cover that enable us to provide the highest level of intellectual capital to our clients through our in depth written research and corporate access services. We are continually adding industry verticals and stocks under coverage. Our current industry specializations include:
Exclusive Relationship with S&P Capital IQ Equity Research
Through an exclusive relationship with S&P Capital IQ Equity Research, Cantor is able to distribute and market co-branded equity research. Cantor-S&P Capital IQ’s equity research further expands our research coverage within the institutional marketplace, while serving as a complimentary extension and robust backdrop to the Cantor core in-house global research effort.
Cantor-S&P Capital IQ research product allows clients have direct access to over 70 equity research analysts covering over 1,600 global companies in the U.S., U.K., Europe and Asia, and enables clients to take advantage of S&P Capital IQ’s extensive corporate access pipeline.
To access our current coverage list, please visit: Cantor U.S. Equity Research Universe. If you are a client and would like to access Cantor Fitzgerald’s in-house research or Cantor’s S&P Capital IQ Equity Research portal, please visit: Cantor U.S. Equity Research Reports.
For more information on Cantor Fitzgerald Equity Research, please contact EquityResearchSales@cantor.com.
LOGIN TO CANTOR SERVICES: